See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: Jan. 4, 2011

Type 2 Diabetes Adolescent Migraines Lupus

(HealthDay News) -- Here are the latest clinical trials, courtesy of

Type 2 Diabetes

This study will evaluate different doses of approved type 2 diabetes drugs. You may qualify if you are aged 18 to 85, have type 2 diabetes, and have been on a stable regimen of NPH insulin, Levemir (insulin determir), or Lantus (insulin glargine) and at least one oral diabetic drug for three months.

The research site is in Las Vegas, Nev.

More information

Please see


Adolescent Migraines

This study will evaluate a nasal spray to treat migraines. Participants must be aged 12 to 17 and be willing to treat one migraine with the study drug exclusively.

The research site is in Colorado Springs, Colo.

More information

Please see



This study will evaluate an injected study medication in treating systemic lupus erythematosus (SLE). To qualify, you must not have had an active infection in the last 30 days, and not have a serious infection or blood-clotting event within 90/180 days respectively.

The research site is in Sacramento, Calif.

More information

Please see


Copyright 2011 All rights reserved.

Consumer News


HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.